Sign in to view content

Pharmacokinetic Profile of the Port Delivery System With Ranibizumab in the Phase 3 Archway Trial

John W. Kitchens, MD

Video
Published 2021

Related

Abicipar for nAMD Provides Faster Retinal Fluid Resolution, and Achieved Similar Dryness Through Week 104 With Fewer Injections
Nancy M. Holekamp, MD, FASRS
Annual Meeting Talks
2020
Effect of Adding Dexamethasone to Continued Ranibizumab Treatment in Patients With Persistent Diabetic Macular Edema
Raj K. Maturi, MD
Annual Meeting Talks
2018
Gene Expression Modifications in Anti-VEGF Treated Retinal Müller Cells
Baruch D. Kuppermann, MD, PhD
Annual Meeting Talks
2016

Category: AMD-Neovascular

See more